Design
Review
Answers are grounded in this paper and cite their sources.
Supports recognition of reversible post-ischemic dysfunction clinically; leaves open targeted metabolic interventions for prospective trials.
The number of identifiable syndromes associated with ischemic heart disease is increasing. As our understanding of the various phenomena that produce ischemic syndromes improves, more complete care of our patients with ischemic abnormalities will be possible.
No takes yet. Share an insight, caveat, or question.
Allen et al. (1996) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: